In October 2023, Structure Therapeutics Inc. closed the transaction. The company has disclosed the placement agent expenses of $17,999,999.721 in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.38 USD | +1.59% | +0.86% | -10.75% |
21/05 | JPMorgan Starts Structure Therapeutics With Overweight Rating | MT |
09/05 | Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.75% | 1.67B | |
+9.99% | 114B | |
+12.01% | 107B | |
-3.07% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.90% | 17.51B | |
-39.36% | 17.17B | |
+5.82% | 14.14B | |
+33.05% | 12.2B |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Structure Therapeutics Inc. announced that it has received $299.999996 million in funding